Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.806,05
-0,14%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ PhaseBio Pharmaceuticals Inc (PHAS) PhaseBio Pharmaceuticals Inc (PHAS) Notizie

PHAS

PhaseBio Pharmaceuticals (PHAS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PHAS
DataOraFonteTitoloSimboloCompagnia
30/05/202322:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
19/05/202322:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202322:23Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
03/04/202322:06Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
14/02/202323:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
21/12/202212:10Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
04/11/202221:44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/10/202214:00Business WirePhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy CodeNASDAQ:PHASPhaseBio Pharmaceuticals Inc
28/09/202218:05TipRanksPhasebio Pharmaceuticals (PHAS) was downgraded to a Hold Rating at NeedhamNASDAQ:PHASPhaseBio Pharmaceuticals Inc
15/08/202212:15TipRanksH.C. Wainwright Keeps Their Buy Rating on Phasebio Pharmaceuticals (PHAS)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
12/08/202222:15TipRanksPhasebio Pharmaceuticals (PHAS) Receives a Buy from NeedhamNASDAQ:PHASPhaseBio Pharmaceuticals Inc
12/08/202214:30Business WirePhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/06/202214:18TipRanks10 Penny Stocks that Could Deliver Exponential ReturnsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
17/05/202212:26TipRanksH.C. Wainwright Thinks Phasebio Pharmaceuticals’ Stock is Going to RecoverNASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202217:55TipRanksAnalysts Offer Insights on Healthcare Companies: Phasebio Pharmaceuticals (PHAS) and Hookipa Pharma (HOOK)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202212:51Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202212:00Business WirePhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for BentracimabNASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202212:00Business WirePhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
22/04/202222:15Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
18/04/202211:35TipRanksAnalysts Offer Insights on Healthcare Companies: Phasebio Pharmaceuticals (PHAS) and InMode (INMD)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
07/04/202222:00Business WirePhaseBio Pharmaceuticals to Participate in the 21st Annual Needham Healthcare ConferenceNASDAQ:PHASPhaseBio Pharmaceuticals Inc
04/04/202214:00Business WirePhaseBio Announces Positive Results from Phase 2b Trial for BentracimabNASDAQ:PHASPhaseBio Pharmaceuticals Inc
25/03/202220:15TipRanksNeedham Thinks Phasebio Pharmaceuticals’ Stock is Going to RecoverNASDAQ:PHASPhaseBio Pharmaceuticals Inc
25/03/202211:25TipRanksH.C. Wainwright Reiterates Their Buy Rating on Phasebio Pharmaceuticals (PHAS)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/03/202221:16Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/03/202221:00Business WirePhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
08/03/202214:00Business WirePhaseBio Pharmaceuticals Announces Bentracimab Manufacturing UpdateNASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/02/202222:00Business WirePhaseBio Pharmaceuticals to Participate in the Cowen 42nd Annual Health Care ConferenceNASDAQ:PHASPhaseBio Pharmaceuticals Inc
10/02/202214:00Business WirePhaseBio Announces Bentracimab Phase 2b Trial Data Accepted for Late Breaking Clinical Research Presentation at the 2022 American College of Cardiology (ACC.22) Annual Scientific SessionNASDAQ:PHASPhaseBio Pharmaceuticals Inc
04/02/202215:31Edgar (US Regulatory)Schedule 13gNASDAQ:PHASPhaseBio Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PHAS

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network